Business Wire

KCI Expands Surgical Incision Management Offering in Europe

Share

KCI, an Acelity Company, today announced the availability of two additional PREVENA™ Therapy offerings in Europe: the PREVENA DUO™ Incision Management System with PEEL & PLACE™ Dressing - 13cm and PREVENA PLUS PEEL & PLACE™ Incision Management System – 35cm. Both of the new introductions incorporate the proven clinical benefits of PREVENA™ Therapy, providing clinicians with solutions to meet the evolving needs of post-surgical incision management. PREVENA™ Therapy helps hold incision edges together and protects incisions from external infectious sources.

The PREVENA DUO™ System is the first single use negative pressure wound therapy (NPWT) system designed specifically for the simultaneous management of two closed surgical incisions, configured to help reduce post-operative complications in bilateral procedures, such as vascular harvesting, breast reconstruction and orthopedic trauma surgeries.

PREVENA PLUS PEEL & PLACE™ System – 35cm is suitable for long incisions commonly used in revision surgery, while also providing higher exudate storage capacity. The PREVENA PLUS™ System offers the proven effectiveness of negative pressure wound therapy with improved versatility, portability, and flexibility.

“Surgical site infections are an issue plaguing heath systems, clinicians and patients around the world,” said R. Andrew Eckert, Chief Executive Officer, KCI. “The ever-growing body of evidence supporting PREVENA™ Therapy continues to demonstrate its efficacy in lowering the incidence of SSIs. In line with our unwavering commitment to patients and our goal of moving healing forward, we hope that as a result of the availability of these two new products, more European patients will be able to benefit from PREVENA™ Therapy and reduce the burden of SSIs.”

“The impact surgical site infections have on patients its significant - delaying their recovery and return to work, causing financial worry and affecting their mental health,” Ron Silverman, M.D., FACS, Chief Medical Officer, KCI. “For those patients who are at increased risk of post-operative complications we need to look carefully at their care to ensure that they recover quickly and effectively. We are proud to be able to introduce the PREVENA DUO™ System and PREVENA PLUS PEEL & PLACE™ System – 35cm in Europe, helping provide clinicians with the tools needed to best serve their patients and provide quality care.”

Surgical site infections (SSIs) present a significant burden in Europe, with more than 500,000 cases in Europe each year.1 SSIs are associated with longer post-operative hospital stays, reduced patient quality of life, may necessitate additional surgical procedures, may require intensive care, and can result in higher morbidity and mortality.2 Infections, the most common surgical site complication, account for up to 20 percent of all of healthcare-associated infections and cost the NHS up to £700 million each year.3,4

Recently, the National Institute for Health and Care Excellence (NICE) published a Medtech Innovation Briefing (MIB) on PREVENA™ Incision Management System. The MIB assesses the most recent published evidence on the technology and surmises that PREVENA™ Therapy can lead to significantly reduced incision site complications in comparison to standard care dressings. Clinical specialists invited to add comment in the report also agreed that using PREVENA™ Therapy would likely lead to cost savings as a result of the reduction in surgical site complications (SSCs) and a reduced need for dressing changes.5

About PREVENA™ Incision Management System

The PREVENA™ System, launched in 2010, is the first disposable negative pressure system designed specifically for the management of closed surgical incisions. The PREVENA™ Incision Management System protects the incision from external contamination, helps hold incision edges together, removes fluid and infection materials, and delivers continuous negative pressure at -125mmHg for up to seven days.

Please refer to the PREVENA™ Incision Management System instructions for use for important limitations and safety information.

About KCI, an Acelity Company

KCI, an Acelity Company, is a well trusted brand in advanced wound care. We are a leader in negative pressure wound therapy, providing solutions for both wound healing and surgical management. Our product offerings are available in more than 90 countries and deliver value through solutions that speed healing. KCI is a leader in quality, safety and customer experience and is committed to advancing the science of healing. Headquartered in San Antonio, Texas, KCI employs approximately 4,500 people worldwide.

1 https://ecdc.europa.eu/en/surgical-site-infections/facts

2 Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank H-P, Ducomble T, et al. (2016) Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study. PLoS Med 13(10): e1002150. https://doi.org/10.1371/journal.pmed.1002150

3 National Institute for Health and Care Excellence. Clinical guideline CG74. Surgical site infections: prevention and treatment. April 2019. Available at: https://www.nice.org.uk/guidance/ng125. Accessed July 15, 2019.

4 Leaper DJ, van Goor H, Reilly J et al. Surgical site infection - a European perspective of incidence and economic burden. Int Wound J 2004; 1: 247–735. Available at: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1742-4801.2004.00067.x

5 National Institute for Health and Care Excellence. Prevena incision management system for closed surgical incisions. Medtech innovation briefing. 28 February 2019. Available at: https://www.nice.org.uk/advice/mib173. Accessed July 15, 2019.

Contact information

Maggie Fairchild
Corporate Communications
Phone: +1-210-330-2666
Email: maggie.fairchild@acelity.com

Caleb Moore
Investor Relations
Phone: +1 (210) 255-6433
Email: caleb.moore@acelity.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

 Vertex Announces Reimbursement of Cystic Fibrosis Medicines SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) for Eligible Patients Ages 12 and Older, and ORKAMBI® (lumacaftor/ivacaftor) in Children Ages 2 to 5, With Certain CFTR Mutations in Australia19.10.2019 23:29:00 CESTPress release

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) is reimbursed in Australia for people with cystic fibrosis (CF) ages 12 years and older who are homozygous for the F508del mutation or who have one copy of the F508del mutation and another responsive residual function (RF) mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. People with CF who have one copy of the F508del mutation and another responsive RF mutation in the CFTR gene will have access to a medicine for the cause of their CF for the first time. In addition, ORKAMBI® (lumacaftor/ivacaftor) is now also reimbursed for the treatment of children with CF ages 2 to 5 who have two copies of the F508del mutation in the CFTR gene. Patients over the age of 6 have already been able to access ORKAMBI® in Australia since October 2018. Following previously received positive recommendations from the Pharmaceutical Benefits Advisory Committee (PB

A&D Resources utvider i Norden19.10.2019 12:57:00 CESTPress release

A&D Resources, den autoriserte distributøren for Hogan Assessments i Danmark og Benelux-landene, utvider forretningsdriften til Finland, Norge og Sverige, noe som gjøre det til den fremste Hogan-distributøren i regionen. Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20191019005034/no/ A&D spesialiserer seg i evaluering og utvikling av enkeltpersoner, grupper og organisasjoner, og er ansett som den fremste evalueringsvirksomheten i Danmark. Denne utvidelsen i Norden kan i stor grad tilskrives organisasjonens suksesshistorie i den omliggende regionen og også på grunn av dens arbeid globalt. «Vi er heldige som har et sterkt omdømme innenfor vår bransje, enten det er i Danmark, Benelux eller utover, og det er fordi vi leverer», sier Hans Ove Dahl, administrerende direktør i A&D. «Vi mener at hvis du bygger opp et talentfullt team ved å bruke Hogans evalueringer, som er allment betraktet som de mest prediktive evalueringene

EURid Launches New Eligibility Criteria19.10.2019 04:30:00 CESTPress release

The top-level internet domain .eu is the eighth largest country code extension on the internet and, as of October 2019, we have more than 3.6 million registrations spread out across Europe. Since its launch in 2006, only companies and individuals residing within the EU and EEA member states have been eligible to register the .eu domain name. However, striving to meet the needs of an ever-changing digital environment, the eligibility criteria for the registration of .eu domain name has now been extended to all EU citizens living around the world. With millions of Europeans living around the world – our hope is to provide these individuals, living far from their native lands, with a personal online platform through which they can share their stories with families and friends back home. “We are excited to be able to extend the registration criteria to EU citizens around the world. The .eu domain is now closer to your ambitions, achievements and dreams. It is the bridge connecting you to y

ams to Launch New Takeover Offer for OSRAM at EUR 41.00 Per Share With Minimum Acceptance Threshold of 55%18.10.2019 17:16:00 CESTPress release

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, announces that it intends to launch a new all-cash takeover offer for OSRAM Licht AG ("OSRAM") for 100% of the share capital of OSRAM at a price of EUR 41.00 per share ("Offer"). The Offer which represents a premium of 42% to the undisturbed OSRAM share price of EUR 28.92 as of 2 July 2019 will be launched by ams Offer GmbH, a newly incorporated, wholly owned subsidiary of ams. ams is the largest shareholder in OSRAM with a direct shareholding of 19.99% which ams will not exceed outside of the Offer. As a result of ams' shareholder position, ams has lowered the minimum acceptance threshold to 55%. Winning way forward for ams and OSRAM The combination of ams and OSRAM allows ams to create a global leader in sensor solutio

Resecurity Appoints Selene Giupponi Managing Director of Resecurity Europe18.10.2019 15:38:00 CESTPress release

Resecurity, a cybersecurity company that delivers in-depth analysis layered on top of the most comprehensive, exclusive sets of data from the Deep and Dark Web, announces that Selene Giupponi has joined as Managing Director and will be based in Italy. A digital forensics expert, Selene adds significant value to Resecurity’s operations in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191018005415/en/ Resecurity Appoints Selene Giupponi Managing Director of Resecurity Europe (Photo: Business Wire) Selene has extensive expertise in digital forensics and is often called as an expert witness regarding digital and mobile forensics on domestic and international cases, investigations and court trials. She is a specialized IT trainer in Italy and teaches digital, mobile, cloud and mainframe forensics, cybercrime and information security at various Italian universities. “Selene brings a depth of experience to our team and we

Secure-24 Completes Acquisition of Symmetry Corporation18.10.2019 14:20:00 CESTPress release

NTT Ltd., the newly formed, world-leading global technology services provider, and Symmetry Holding Inc. (Symmetry), a U.S.-based leading provider of SAP managed services, today announced that Secure-24 Intermediate Holdings, Inc. (Secure-24), part of the Managed Services division of NTT Ltd., has completed the acquisition of Symmetry Corporation effective October 17, 2019. “The powerful business combination of Secure-24 and Symmetry leverages the strengths of both companies around Secure-24’s foundation of delivering managed IT operations, application hosting and cloud services to enterprises worldwide,” said Mike BeDell, Chief Executive Officer, Secure-24. “As we begin to integrate Symmetry’s portfolio into Secure-24’s portfolio, through a shared vision, we look forward to providing even greater value that accelerates our clients’ business success.” Symmetry, headquartered in Brookfield, Wisconsin, will expand the scale of SAP managed services capabilities of Secure-24 and bring new